SI2032551T1 - Antitumorne dihidropiran-2-on spojine - Google Patents

Antitumorne dihidropiran-2-on spojine

Info

Publication number: SI2032551T1
Authority: SI; Slovenia
Prior art keywords: compounds; antitumoral; dihydropyran; antitumoral dihydropyran
Prior art date: 2006-06-16

Application number

SI200730781T

Other languages

English (en)

Inventor

Lopez M Jesus Martin

Molinero Laura Coello

Benitez Jose Fernando Reyes

Vicente Alberto Rodriguez

Garcia-Ibarrola Maria Garranzo

Perez Carmen Murcia

Solloso Andres Francesch

Sancho Francisco Sanchez

Marchante Maria Del Carmen Cuevas

Rodriguez Rogelio Fernandez

Original Assignee

Pharma Mar Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-16

Filing date

2007-06-15

Publication date

2012-01-31

2007-06-15 Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa

2012-01-31 Publication of SI2032551T1 publication Critical patent/SI2032551T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pyrane Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)

SI200730781T 2006-06-16 2007-06-15 Antitumorne dihidropiran-2-on spojine SI2032551T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP06380173		2006-06-16
PCT/EP2007/055959 WO2007144423A1 (en)	2006-06-16	2007-06-15	Antitumoral dihydropyran-2-one compounds
EP07765445A EP2032551B9 (en)	2006-06-16	2007-06-15	Antitumoral dihydropyran-2-one compounds

Publications (1)

Publication Number	Publication Date
SI2032551T1 true SI2032551T1 (sl)	2012-01-31

Family

ID=38508885

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200730781T SI2032551T1 (sl)	2006-06-16	2007-06-15	Antitumorne dihidropiran-2-on spojine

Country Status (29)

Country	Link
US (2)	US8324406B2 (sl)
EP (3)	EP2404912A3 (sl)
JP (2)	JP5117491B2 (sl)
KR (1)	KR101474031B1 (sl)
CN (2)	CN102336730A (sl)
AR (1)	AR061506A1 (sl)
AT (1)	ATE522514T1 (sl)
AU (1)	AU2007259257B8 (sl)
BR (2)	BRPI0722429A2 (sl)
CA (1)	CA2654334C (sl)
CY (1)	CY1112103T1 (sl)
DK (1)	DK2032551T3 (sl)
ES (1)	ES2371942T3 (sl)
HR (1)	HRP20110845T1 (sl)
IL (1)	IL195676A (sl)
MX (1)	MX2008015754A (sl)
MY (1)	MY145788A (sl)
NO (2)	NO341508B1 (sl)
NZ (1)	NZ573706A (sl)
PL (1)	PL2032551T3 (sl)
PT (1)	PT2032551E (sl)
RS (1)	RS52034B (sl)
RU (2)	RU2444519C2 (sl)
SG (1)	SG174830A1 (sl)
SI (1)	SI2032551T1 (sl)
TW (2)	TW201213316A (sl)
UA (1)	UA97369C2 (sl)
WO (1)	WO2007144423A1 (sl)
ZA (1)	ZA200810315B (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101903367B (zh)	2007-12-20	2015-08-05	法马马有限公司	抗肿瘤化合物
ES2411930T3 (es)	2008-02-20	2013-07-09	Actelion Pharmaceuticals Ltd.	Compuestos antibióticos azatricíclicos
JP5404652B2 (ja)	2008-02-22	2014-02-05	アクテリオンファーマシューティカルズリミテッド	オキサゾリジノン誘導体
MY158520A (en)	2008-10-07	2016-10-14	Actelion Pharmaceuticals Ltd	Tricyclic oxazolidinone antibiotic compounds
WO2010041218A2 (en)	2008-10-10	2010-04-15	Actelion Pharmaceuticals Ltd	Oxazolidinyl antibiotics
WO2010149688A2 (en)	2009-06-24	2010-12-29	Pharma Mar, S.A.	Antitumoral compounds
GB201309807D0 (en) *	2013-05-31	2013-07-17	Pharma Mar Sau	Antibody drug conjugates
CN108467378A (zh) *	2017-02-23	2018-08-31	复旦大学	一种二氢吡喃酮类化合物及其制备方法和用途
JOP20190254A1 (ar)	2017-04-27	2019-10-27	Pharma Mar Sa	مركبات مضادة للأورام
CN110790737B (zh) *	2019-11-07	2022-07-22	河南中烟工业有限责任公司	一种2,3-二氢-3,5-二羟基-6-乙基-4h-吡喃-4-酮的制备方法
US20250243174A1 (en)	2021-10-21	2025-07-31	Pharma Mar, S.A.	Antitumoral compounds
CN117510448A (zh) *	2023-11-13	2024-02-06	贵州中医药大学	一种二氢吡喃酮衍生物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA938019B (en) *	1992-11-13	1995-04-28	Upjohn Co	Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
SI1142887T1 (sl) *	1993-11-19	2004-08-31	Parke, Davis & Company	Derivati 5,6-dihidropirona kot inhibitorji proteaze in antivirusna sredstva
US7446196B2 (en) *	2004-06-03	2008-11-04	Kosan Biosciences, Incorporated	Leptomycin compounds

2007
- 2007-06-15 EP EP11177474A patent/EP2404912A3/en not_active Withdrawn
- 2007-06-15 UA UAA200900292A patent/UA97369C2/ru unknown
- 2007-06-15 SG SG2011067998A patent/SG174830A1/en unknown
- 2007-06-15 RS RS20110495A patent/RS52034B/sr unknown
- 2007-06-15 NZ NZ573706A patent/NZ573706A/en not_active IP Right Cessation
- 2007-06-15 EP EP11177479A patent/EP2404913A3/en not_active Withdrawn
- 2007-06-15 WO PCT/EP2007/055959 patent/WO2007144423A1/en not_active Ceased
- 2007-06-15 CN CN2011102036625A patent/CN102336730A/zh active Pending
- 2007-06-15 AU AU2007259257A patent/AU2007259257B8/en not_active Ceased
- 2007-06-15 CA CA2654334A patent/CA2654334C/en active Active
- 2007-06-15 HR HR20110845T patent/HRP20110845T1/hr unknown
- 2007-06-15 PT PT07765445T patent/PT2032551E/pt unknown
- 2007-06-15 CN CN2007800222645A patent/CN101679340B/zh not_active Expired - Fee Related
- 2007-06-15 KR KR1020097000830A patent/KR101474031B1/ko not_active Expired - Fee Related
- 2007-06-15 SI SI200730781T patent/SI2032551T1/sl unknown
- 2007-06-15 MY MYPI20085040A patent/MY145788A/en unknown
- 2007-06-15 EP EP07765445A patent/EP2032551B9/en active Active
- 2007-06-15 AT AT07765445T patent/ATE522514T1/de active
- 2007-06-15 ES ES07765445T patent/ES2371942T3/es active Active
- 2007-06-15 US US12/304,123 patent/US8324406B2/en not_active Expired - Fee Related
- 2007-06-15 BR BRPI0722429-0A patent/BRPI0722429A2/pt not_active IP Right Cessation
- 2007-06-15 DK DK07765445.7T patent/DK2032551T3/da active
- 2007-06-15 PL PL07765445T patent/PL2032551T3/pl unknown
- 2007-06-15 JP JP2009514811A patent/JP5117491B2/ja not_active Expired - Fee Related
- 2007-06-15 RU RU2009101150/04A patent/RU2444519C2/ru active
- 2007-06-15 MX MX2008015754A patent/MX2008015754A/es active IP Right Grant
- 2007-06-15 BR BRPI0713031A patent/BRPI0713031B8/pt not_active IP Right Cessation
- 2007-06-19 AR ARP070102670A patent/AR061506A1/es active IP Right Grant
- 2007-06-20 TW TW100146802A patent/TW201213316A/zh unknown
- 2007-06-20 TW TW096122071A patent/TWI373469B/zh not_active IP Right Cessation
2008
- 2008-12-02 IL IL195676A patent/IL195676A/en active IP Right Grant
- 2008-12-04 ZA ZA2008/10315A patent/ZA200810315B/en unknown
2009
- 2009-01-06 NO NO20090054A patent/NO341508B1/no unknown
2011
- 2011-06-29 US US13/171,567 patent/US8501968B2/en not_active Expired - Fee Related
- 2011-08-05 RU RU2011133128/04A patent/RU2011133128A/ru not_active Application Discontinuation
- 2011-09-14 NO NO20111248A patent/NO20111248L/no not_active Application Discontinuation
- 2011-10-05 JP JP2011220925A patent/JP2012021023A/ja active Pending
- 2011-11-30 CY CY20111101175T patent/CY1112103T1/el unknown

Also Published As

Publication number	Publication date
US8501968B2 (en)	2013-08-06
EP2404913A3 (en)	2012-06-06
US20090186938A1 (en)	2009-07-23
AU2007259257A8 (en)	2012-04-05
RU2009101150A (ru)	2010-07-27
PL2032551T3 (pl)	2012-01-31
BRPI0713031B8 (pt)	2021-05-25
HK1130052A1 (en)	2009-12-18
NO341508B1 (no)	2017-11-27
JP5117491B2 (ja)	2013-01-16
JP2009539943A (ja)	2009-11-19
ZA200810315B (en)	2010-02-24
CN102336730A (zh)	2012-02-01
EP2404913A2 (en)	2012-01-11
CN101679340A (zh)	2010-03-24
AU2007259257B8 (en)	2012-04-05
KR101474031B1 (ko)	2014-12-17
RU2444519C2 (ru)	2012-03-10
IL195676A (en)	2012-06-28
EP2032551B9 (en)	2012-02-29
CN101679340B (zh)	2013-06-05
MX2008015754A (es)	2009-01-12
IL195676A0 (en)	2009-09-01
EP2404912A2 (en)	2012-01-11
KR20090024261A (ko)	2009-03-06
BRPI0722429A2 (pt)	2013-11-26
ATE522514T1 (de)	2011-09-15
TWI373469B (en)	2012-10-01
CA2654334A1 (en)	2007-12-21
RU2011133128A (ru)	2013-02-10
EP2032551A1 (en)	2009-03-11
TW201213316A (en)	2012-04-01
US20100048690A2 (en)	2010-02-25
HRP20110845T1 (hr)	2011-12-31
TW200811128A (en)	2008-03-01
UA97369C2 (ru)	2012-02-10
NZ573706A (en)	2011-09-30
BRPI0713031A2 (pt)	2013-03-12
PT2032551E (pt)	2011-12-06
CY1112103T1 (el)	2015-11-04
EP2404912A3 (en)	2012-07-25
AU2007259257B2 (en)	2011-12-08
EP2032551B1 (en)	2011-08-31
ES2371942T3 (es)	2012-01-11
US8324406B2 (en)	2012-12-04
BRPI0713031B1 (pt)	2020-10-06
AU2007259257A1 (en)	2007-12-21
US20120190870A1 (en)	2012-07-26
CA2654334C (en)	2014-06-10
AR061506A1 (es)	2008-09-03
NO20090054L (no)	2009-01-06
JP2012021023A (ja)	2012-02-02
MY145788A (en)	2012-04-30
SG174830A1 (en)	2011-10-28
WO2007144423A1 (en)	2007-12-21
DK2032551T3 (da)	2012-01-02
RS52034B (sr)	2012-04-30
NO20111248L (no)	2008-12-16

Publication	Publication Date	Title
GB0602424D0 (en)	2006-03-22	Compounds
IL195676A0 (en)	2009-09-01	Antitumoral dihydropyran-2-one compounds
GB0602046D0 (en)	2006-03-15	Compounds
EP1984379A4 (en)	2011-05-18	ANTI-ARENAVIRAL COMPOUNDS
EP2082022A4 (en)	2011-12-07	COMPOUNDS
EP2004174A4 (en)	2010-07-28	NAPHTHALENEDIONED COMPOUNDS
ZA200800615B (en)	2009-01-28	Antitumoral compounds
GB0523098D0 (en)	2005-12-21	Antitumoral compounds
GB0602042D0 (en)	2006-03-15	Compounds
AP2009004767A0 (en)	2009-02-28	Cubstituted azolin-2-yl-amino compounds
EP1973905A4 (en)	2010-12-08	COMPOUNDS
GB0602412D0 (en)	2006-03-15	Compounds
GB0602560D0 (en)	2006-03-22	Compounds
GB0600427D0 (en)	2006-02-15	Compounds
GB0622870D0 (en)	2006-12-27	Antitumoral compounds
GB0605081D0 (en)	2006-04-26	Antitumoral compounds
GB0623952D0 (en)	2007-01-10	Antitumoral compounds
GB0722495D0 (en)	2007-12-27	Antitumoral compounds
GB0704990D0 (en)	2007-04-25	Antitumoral compounds
GB0723376D0 (en)	2008-01-09	Antitumoral compounds
GB0520279D0 (en)	2005-11-16	Antitumoral compounds
GB0524251D0 (en)	2006-01-04	Antitumoral compounds
GB0523164D0 (en)	2005-12-21	Antitumoral compounds
GB0520292D0 (en)	2005-11-16	Antitumoral compounds
GB0524165D0 (en)	2006-01-04	Antitumoral compounds